BioCardia (BCDA)
(Delayed Data from NSDQ)
$2.98 USD
-0.14 (-4.49%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $2.90 -0.08 (-2.68%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-1.19 | 0.00% |
Earnings Summary
For their last quarter, BioCardia (BCDA) reported earnings of -$0.88 per share, missing the Zacks Consensus Estimate of -$0.10 per share. This reflects a negative earnings surprise of 780.00%. Look out for BCDA's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$1.19 per share, reflecting a year-over-year increase of 33.89%.
Earnings History
Price & Consensus
Zacks News for BCDA
BioCardia (BCDA) Soars 168% on FDA Nod to Heart Failure Study
BCDA: What are Zacks experts saying now?
Zacks Private Portfolio Services